5 results
Main objective: To assess the effect of CK-2127107 versus placebo on respiratory function in patients with ALS.
Primary objective:The main objective of the present trial are:• to evaluate the effect of TW001 on oxidative stress biomarkers• to evaluate the safety of TW001 in patients with Alzheimer*s DiseaseSecondary objective:The secondary objective of the…
To assess the effect of treatment with 100 mg of FAB122 (edaravone) on disease progression in patients with ALS.
The purpose of this study is to evaluate whether the new drug reldesemtiv is effective and safe in patients with ALS. The primary objective is to assess the effect of reldesemtiv versus placebo on functional outcomes in ALS.The secondary objectives…
To assess the effect of treatment with 100 mg of FAB122 (edaravone) on disease progression in patients with ALS.